NOV 14, 2020 3:30 PM PST

Half of CBD Users Test Positive for THC in Urine Tests

WRITTEN BY: Annie Lennon

Despite the growing popularity of cannabidiol (CBD) products, there has been little research directly assessing whether the usage of high-CBD products can deliver positive results on urinary drug tests for THC. Now, however, researchers have found that patients who regularly use products containing CBD may test positive in urine tests screening for tetrahydrocannabinol (THC). 

For the study, the researchers studied 14 participants at McLean Hospital in Belmont, Massachusetts, between June 201 8and February 2020. Each was instructed not to use any other cannabis/ cannabinoid-based product throughout the trial. All in all, the participants included 11 women and 12 white individuals. 

The study period lasted for four weeks. During this time, each person administered a study product containing 1.04% CBD and 0.02% THC under their tongue three times per day for a targeted daily dose of around 30mg of CBD and just less than 1 mg of THC.

In the end, they found that after four weeks of daily dosage, 50% of the participants, or seven people, tested positive for THC from urine tests, while the other half tested negative. Gas chromatography-mass spectrometry tests then confirmed these results.

While interesting findings, the investigators say that further research is needed to confirm their results. In particular, they say that studies with larger sample sizes are necessary to assess which variables (ranging from product use to body mass index, age, race, and medication use) contribute to positive THC results. Also, given that the cannabinoid blend used in their study was 0.02% THC and that the upper THC limit for CBD products is 0.3%, further studies looking at results when higher quantities of THC are administered are also needed. 

“It is often assumed individuals using hemp-derived products will test negative for THC.” write the researchers in their paper. "Current results indicate this may not be true, especially if assays are more sensitive than advertised, underscoring the potential for adverse consequences, including loss of employment and legal or treatment ramifications, despite the legality of hemp-derived products.”

 

Sources: High TimesJAMA Psychiatry

About the Author
University College London
Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
JUN 24, 2022
Cannabis Sciences
Decrease in Youth Substance Use During the Pandemic
JUN 24, 2022
Decrease in Youth Substance Use During the Pandemic
A review published in Child and Family Disaster Psychiatry found that youth substance use declined during the COVID-19 p ...
JUL 20, 2022
Cannabis Sciences
Why Health Experts Consider Delta 8 THC Dangerous
JUL 20, 2022
Why Health Experts Consider Delta 8 THC Dangerous
Delta 8 is booming in popularity, but health experts are concerned. Here's why.
OCT 13, 2022
Cannabis Sciences
High Doses of CBD Safe for Driving
OCT 13, 2022
High Doses of CBD Safe for Driving
The University of Sydney research team studied the effects of cannabidiol (CBD) on driving, and they found that the high ...
NOV 04, 2022
Health & Medicine
Cannabis Users and Liver Transplants
NOV 04, 2022
Cannabis Users and Liver Transplants
Are cannabis consumers eligible for liver transplants? Here's the details
DEC 01, 2022
Cannabis Sciences
The first medical marijuana research bill
DEC 01, 2022
The first medical marijuana research bill
The first medical marijuana research bill is coming. Here's the details, and what it could mean for the science communit ...
DEC 02, 2022
Cancer
No Evidence that Cannabis Relieves Symptoms in Advanced Cancer Patients
DEC 02, 2022
No Evidence that Cannabis Relieves Symptoms in Advanced Cancer Patients
Palliative care describes a class of healthcare intended to enhance patients' quality of life with severe, life-thre ...
Loading Comments...